Hong Kong Stocks End in Green; Junshi Bio Gains 3%

MT Newswires Live
09/08

Hong Kong stocks ended higher Monday as markets analyzed the latest trade data from China and investors factored in a chance of a major rate cut in the U.S.

The Hang Seng Index gained 215.93 points, or 0.9%, to 25,633.91, while the Hang Seng China Enterprises Index rose 64.44 points, or 0.71%, to 9,121.66.

China's exports jumped by 4.4% in August, while imports rose by 1.3%, according to official data. The figures missed the respective 5% and 3% growth predicted by analysts polled by Reuters.

Meanwhile, markets increasingly expected the Federal Open Market Committee to cut rates next week after the U.S. reported dismal labor data, Reuters reported.

In corporate news, Hesai Group (HKG:2525) launched its initial public offering in Hong Kong, seeking to raise as much as HK$3.88 billion from the deal.

The three-dimensional light detection developer is offering up to 17 million shares at an indicative price of HK$228.00 apiece, according to an filing with the Hong Kong Exchange.

Elsewhere, Shanghai Junshi Biosciences (HKG:1877, SHA:688180) said its experimental dermatology drug JS005 achieved "positive results" in a phase 3 clinical trial.

Shares closed nearly 3% higher.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10